CN104342409A - Preparation method of recombinant ginseng superoxide dismutase (rgSOD) - Google Patents
Preparation method of recombinant ginseng superoxide dismutase (rgSOD) Download PDFInfo
- Publication number
- CN104342409A CN104342409A CN201410535835.7A CN201410535835A CN104342409A CN 104342409 A CN104342409 A CN 104342409A CN 201410535835 A CN201410535835 A CN 201410535835A CN 104342409 A CN104342409 A CN 104342409A
- Authority
- CN
- China
- Prior art keywords
- seq
- nucleotide sequence
- ginseng
- superoxide
- dismutase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides a nucleotide sequence of a signal peptide suitable for escherichia coli to carry out secretory expression on recombinant ginseng superoxide dismutase (rgSOD), an SOD nucleotide sequence for coding gSOD, a carrier containing the nucleotide sequences, an engineering cell containing the carrier and a method for purifying rgSOD from the engineering cell. An optimized SOD gene is very suitable for being expressed by escherichia coli and has the characteristics of high expression, high stability and high secretion. The rgSOD pure product can be efficiently, simply and conveniently obtained at a low cost. The invention also provides application of rgSOD prepared by the method to preparation of medicines, food, health care products and cosmetics for treating human aging related diseases or pathologic symptoms.
Description
Technical field
The present invention relates to E. coli secretion and express the nucleotide sequence of the nucleotide sequence of the coded signal peptide of restructuring ginseng superoxide-dismutase and coding ginseng SOD, the carrier containing above-mentioned nucleotide sequence, the engineering cell containing aforementioned bearer and from method of this project cell purification rcSOD and uses thereof, belong to genetically engineered and art of protein biochemistry.
Background technology
Superoxide-dismutase (Superoxide Dismutase, EC1.15.1.1, SOD) is a kind of metalloenzyme be extensively present in animals and plants, microorganism.Superoxide radical (O in energy catalysis biological body
2-) there is disproportionation reaction, be O in body
2-natural remover (Li Ruizhen, Yang Qingjian, Chen Yirui. the mensuration that superoxide-dismutase (SOD) is active and applied research thereof. Hainan Qiong Zhou college journal, October 28 days: 34-36 in 2004).Thus remove O
2-, play a part very important in the self-protection system of organism.SOD is a kind of active substance coming from life entity, can eliminate the objectionable impurities that organism produces in metabolic processes.To human body constantly supplement SOD have antidotal special-effect (Zhu Chinese, Wang Zanshun. Aging Mechanism research in hemocuprein. foreign medical science senile disease fascicle, 1985. (1): 49 ~ 54; Civilian firewood recklessly, Zhong Fusun, Han Xianfa etc. the analysis of lipid peroxide and hemocuprein in normal people, hyperlipidemia, cardiovascular diseases blood. biochemical drug magazine, 1988 (2): 48 ~ 50).Superoxide-dismutase be the people such as Marn in 1938 first from ox red blood corpuscle be separated obtain superoxide-dismutase count, to the research of SOD, oneself has the history of seven more than ten years to people.McCord in 1969 etc. rediscover this albumen, and have found their biological activity, have understood fully the character of its catalysis superoxide anion generation disproportionation reaction, so formal by its called after superoxide-dismutase.SOD is almost from people to cell, from animal to plant, there is its existence (Reis s.Rat liver sup eroxide dism utase purif icat ionand ager elat ed m odificat ion.E uropan J.Biochem.1976,63:617 ~ 623), three kinds can be divided into by its containing metal prothetic group difference, the first is the title (Cu.Zn-SOD) of cupric (Cu) zinc (Zn) metal prothetic group, a kind of enzyme the most common, in green, be mainly present in body cell slurry; The second is the title (Mn-SOD) containing manganese (Mn) metal prothetic group, in purple, is present in eukaryotic plastosome and prokaryotic cell prokaryocyte; The third is the title (Fe-SOD) of iron content (Fe) metal prothetic group, in tawny, is present in prokaryotic cell prokaryocyte.
Ginseng superoxide-dismutase (Cu/Zn type) full length protein 152 amino acid, single peptide chain molecule amount is 15.3KD, exists with dimeric forms.
With the development of bio-science technology, people start gene engineering research and express SOD, but often exist with the inclusion bodies of non-activity at expression in escherichia coli SOD, although people have attempted many refolding methods, eventually because cost is high, renaturation yield is low etc. reason, be difficult to realize industrialization scale operation requirement.Afterwards, researcher has been inquired into and has been utilized eukaryote yeast secreted expression, obtain comparatively satisfied result, at present, the restructuring SOD of listing, all produce with intestinal bacteria intracellular expression or yeast expression, although employing high density fermentation, expression level is low, adds the purifying process (needing reversed phase chromatography) of the complexity brought thus, productive rate is lower, and this low-yield can not be met the need of market.Except application escherichia expression system, people also attempt to utilize the expression systems such as genus bacillus, cereuisiae fermentum and mammalian cell to produce SOD.Adopt eukaryotic expression system can realize the activity of SOD, but regrettably, because expression level is low, high in cost of production factor, almost nobody adopt these expression systems to produce SOD at present.And the research of E. coli secretion expression system is wherein most important trend.
The present inventor is by repeatedly screening, find a gene (SEQ ID NO:1) that can be used for the secreting signal peptide section coding of secreting, expressing ginseng superoxide dismutase proteins, merge with ginseng superoxide-dismutase encoding gene (SEQ ID NO:3) and form signal peptide-ginseng superoxide-dismutase encoding gene, after building prokaryotic expression carrier, proceed in e. coli bl21 (DE3) cell, thus achieve the high-level secretory expression rgSOD of rgSOD, complete the present invention on this basis.
Present system optimization, change the method for engineered E. coli cell obtaining SOD, the transport piece utilizing bacillus coli gene to express and SOD amalgamation and expression obtain more satisfied result, and by the improvement of zymotechnique, easy purifying process simultaneously, acquisition high expression level, high yield pulp1, high reactivity have a kind of rgSOD production method of industrialization value.
Summary of the invention
Based on the shortcoming of prior art, the object of this invention is to provide the nucleotide sequence of above-mentioned signal peptide of encoding, carrier, the engineering cell containing aforementioned bearer and the method from this project cell purification rgSOD containing this signal peptide nucleotide sequence and ginseng SOD nucleotide sequence.
The present inventor is surprised to find, before expressing the ginseng SOD nucleotide sequence as shown in SEQ ID NO:3, add the signal peptide nucleotide sequence as shown in SEQ ID NO:1, unexpectedly can obtain the carrier of the ginseng SOD of high amalgamation and expression, and use the SOD of this vector expression to be easy to purifying, purity is high, receipts amount large, active high.
Of the present invention in another, provide a kind of add before the nucleotide sequence of coding ginseng superoxide-dismutase one can make ginseng Expression of Superoxide Dismutase after be secreted into the transport piece nucleotide sequence in cell walls and plasmalemma gap, described nucleotide sequence SEQ ID NO:1 can encode the aminoacid sequence shown in SEQ ID NO:2, and described nucleotide sequence SEQ ID NO:1 and ginseng superoxide-dismutase coding region sequence SEQ ID NO:3 merges and forms nucleotide sequence SEQ ID NO:5.
In another aspect of the invention, provide a kind of expression vector, it contains the above-mentioned nucleotide sequence of the present invention.Preferably, described expression vector is pET22b.
In another aspect of the invention, provide a kind of engineering cell, it is obtained by the Sequence Transformed host cell of described expression vector, and is integrated with the nucleotide sequence of coding recombinant superoxide dismutase in expression vector.
Preferably, described engineering cell is coli strain is BL21 (DE3).
Of the present invention further in, provide a kind of expression method of producing ginseng superoxide-dismutase, comprise the following steps: under applicable expression condition, cultivate the above-mentioned host cell of the present invention, thus secreting, expressing ginseng superoxide-dismutase; Preferably, described host cell is coli strain is BL21 (DE3).Described cultivation comprises: cultivate and be divided into cultivation stage and induction period, and cultivation stage is cultivated bacterial concentration and reached OD600, and time inductive phase is 18-21hr, and fermentation and inducing temperature remain on 16-25 DEG C, and IPTG consumption is 0.05-1mM/L, and the pH value of inductive phase is 6-8.Described e. coli host cell comprises can use IPTG Induced synthesis ginseng superoxide-dismutase, and can be secreted into the Bacillus coli cells in cell walls and plasmalemma gap.
In another aspect of the present invention, carry out slightly carrying and being further purified to restructuring ginseng SOD after expression.It comprises the steps: (1) collects thalline to fermented sample by centrifugal and/or filter type, with N,O-Diacetylmuramidase process thalline, clear liquid is obtained again by centrifugal method, (2) by saltout and/or after ultrafiltration carries out preliminary purification, or directly by anionresin, hydrophobic chromatography method, obtain the sterling that purity reaches more than 95% (as 95-99.9%), the restructuring ginseng SOD prepared by the present invention is active in 5500U or more than 6000U.
In another aspect of the present invention, the invention provides and use the purposes of the restructuring ginseng SOD for preparing of aforesaid method in the medicine of preparation treatment and human superoxide dismutase relative disease or pathological symptom, food, healthcare products and makeup thereof.Described restructuring ginseng superoxide-dismutase contains arbitrary following aminoacid sequence:
A) aminoacid sequence shown in SEQ ID NO.2; And/or
B) aminoacid sequence shown in SEQ ID NO.4; Or
C) aminoacid sequence shown in SEQ ID NO.6.
Major advantage of the present invention is: the link secretion signal peptide gene after (1) optimization is very applicable to escherichia coli expression, has the feature of high expression level, high stable, hypersecretion; (2) host strain of the superoxide dismutase gene containing secreting signal peptide has the characteristic of high-density growth, is very suitable for the fermentative production of genetically engineered drug large scale and high density.The hgSOD of escherichia coli expression is secreted into cell walls and plasmalemma gap with solubility, tool activity form; Product must renaturation, directly can carry out purifying; Simultaneously because expression level is high, purifying process complexity simplifies greatly, and yield is greatly improved; (3), compared with expressing with eukaryotic system, cost reduces greatly, and industrialization value is improved significantly.
Accompanying drawing explanation
Fig. 1 display is used for the nucleotide sequence of code book invention signal peptide.
The aminoacid sequence of Fig. 2 signal peptide of the present invention.
Fig. 3 display is used for the nucleotide sequence of code book invention natural ginseng SOD.
The aminoacid sequence of Fig. 4 natural ginseng SOD of the present invention.
Fig. 5 display is used for the nucleotide sequence of code book invention restructuring ginseng SOD.
Fig. 6 the present invention recombinates the aminoacid sequence of ginseng SOD.
Fig. 7 is used for the corresponding diagram of the nucleotide sequence of code book invention signal peptide and the aminoacid sequence by the signal peptide of the present invention of its presumption.
Fig. 8 is used for the corresponding diagram that code book invents the nucleotide sequence of the restructuring ginseng SOD of warm expression and the aminoacid sequence by the restructuring ginseng SOD of the warm expression of the present invention of its presumption.
Fig. 9 is the structure schematic diagram of a kind of expression plasmid pET-rgSOD of the present invention.
Figure 10 is that under shaking flask 37 DEG C of conditions, rgSOD expresses electrophorogram.Each swimming lane is as follows: before swimming lane 1, induction; After swimming lane 2, induction, induce sampling in 4 hours, SDS-PAGE electrophoresis detection expression.
Figure 11 is that (IPTG concentration is 1mM/L) rgSOD expresses electrophorogram under condition of different temperatures.Induce after 20 hours, collect thalline, with N,O-Diacetylmuramidase under 37 DEG C of conditions, process 2 hours, centrifugal 10 minutes of 15000rpm, gets supernatant, and SDS-PAGE detects expression.
Figure 12 is the impact of IPTG concentration on rgSOD expression level.Under 20 DEG C of conditions, use the IPTG abduction delivering of 0.6mM, 0.4mM, 0.2mM, 0.1mM concentration respectively.Induce after 20 hours, collect thalline, with N,O-Diacetylmuramidase under 37 DEG C of conditions, process 2 hours, centrifugal 10 minutes of 15000rpm, gets supernatant, and SDS-PAGE detects expression.
Figure 13 is the expression electrophorogram of rgSOD in 6.5L fermentor tank.Each swimming lane is as follows: sampling before swimming lane 1, induction; Swimming lane 2, induction sampling in 20 hours.
Figure 14 is the electrophorogram of the rgSOD after purifying.In 6.5L fermentor tank, express rgSOD, collect thalline, with N,O-Diacetylmuramidase under 37 DEG C of conditions, process 2 hours, centrifugal 10 minutes of 15000rpm, gets supernatant, with the protein SDS-PAGE electrophorogram that anion-exchange chromatography, hydrophobic chromatography are later.
Embodiment
In order to provide, substance of the present invention be understood, describe some aspect of the present invention, pattern, embodiment, modification and feature with different the level of details hereinafter.
In the practice of the invention, employ molecular biology, genetic engineering, genetics, Cell. Mol, biological chemistry, protein biochemistry, protein biochemistry engineering, pharmaceutical technology, medical science, physiology, pathology, experimentation on animals, (the Molecular Cloning:A Laboratory Manual such as Sambrook, 2nd edition, 1989, Cold Spring Harbor Laboratory Press) etc. a lot of conventional art and basic theory.These technology are known.
In an embodiment of the invention, provide a kind of restructuring ginseng superoxide-dismutase, wherein, described ginseng superoxide-dismutase comprises arbitrary following aminoacid sequence:
A) aminoacid sequence shown in SEQ ID NO.2; And/or
B) aminoacid sequence shown in SEQ ID NO.4; Or
C) aminoacid sequence shown in SEQ ID NO.6.
In another embodiment of the present invention, provided the nucleotide sequence of the described signal peptide of coding and ginseng superoxide-dismutase by molecular cloning.
Term of the present invention " nucleotide sequence " comprises DNA and RNA of genomic dna, cDNA, synthesis.Preferably, it refers to DNA, is more preferably the cDNA of encoding sequence.The present invention is also contained coding and is had the enzyme of special properties as herein defined or the nucleotide sequence of albumen.Term used herein " nucleotide sequence " refers to oligonucleotide sequence or polynucleotide sequence and its variant, homologue, fragment and derivative (as its part).Described nucleotide sequence can be derived from genome or synthetics or thing of recombinating, and it can be (no matter it represents positive-sense strand or antisense strand) nucleic acid molecule of double-strand or strand.
In a specific embodiment of the present invention, provide a kind of nucleic acid molecule of separation, wherein, the nucleic acid molecule of described separation comprises arbitrary following nucleotide sequence:
A) nucleotide sequence shown in SEQ ID NO.1 of the aminoacid sequence of coding SEQ ID NO:2; And/or
B) nucleotide sequence shown in SEQ ID NO.3 of the aminoacid sequence of coding SEQ ID NO:4; Or
C) nucleotide sequence shown in SEQ ID NO.5 of the aminoacid sequence of coding SEQ ID NO:6.
The nucleotide sequence that coding has enzyme as herein defined or albumen can obtain from producing any cell of described enzyme or albumen or biology to be separated.Various methods for separating of nucleotide sequence are all well known in the art.Be only citing character herein, such as utilize strong denaturant to extract total serum IgE, utilize and transcribe and reverse transcription method, the chromosomal DNA or the messenger RNA(mRNA) (mRNA) that produce the biology of described enzyme or albumen build genomic dna and/or cDNA library.
Further, also can be prepared the nucleotide sequence of the described enzyme of coding or albumen by the standard method of maturation by synthesis, for another example, utilize synthetic oligonucleotide on automatic dna synthesizer, be then purified, anneal, connect and be cloned in suitable carrier.
Therefore, described nucleotide sequence can be derived from the genome of mixing and synthesis source, the synthesis of mixing and the genome of cDNA source or mixing and cDNA source, its according to standard technique by connect be derived from synthesis, fragment that is genomic or cDNA obtains as required.The fragment of each connection corresponds to the different piece of whole nucleotide sequence.Described DNA sequence dna also can use specific primer to pass through polymerase chain reaction (PCR) to prepare.
Term " PCR " is referred to as polymerase chain reaction (polymerase chain reaction herein, PCR) refer under the catalysis of archaeal dna polymerase, by sex change, withdraw from a secret society or underworld gang, polymerization amplification waits iterative cycles to reach the region of DNA section of geometry order of magnitude amplification between two sections of known arrays.
Polynucleotide of the present invention (nucleotide sequence) can be used to prepare primer, as PCR primer, for the primer of optional amplified reaction; Maybe polynucleotide can be cloned in carrier.The length of described primer and other fragment can be at least 12, as at least 15, be preferably at least 20, as at least 25,30,35 or 40 Nucleotide, and it is also encompassed in as the term is employed herein within polynucleotide.
Usually, recombinant DNA technology (DNA namely recombinated) preparation coding is used to have the enzyme of special properties as herein defined or the nucleotide sequence of albumen.Therefore, in an Alternate embodiments of the present invention, chemical process known in the art can be used to synthesize all or part of nucleotide sequence.
Usually, prepare primer by synthetic method, the method comprises progressively prepares required nucleotide sequence in the mode of next Nucleotide every.Be easy in this area obtain and use automatic technology to realize the technology of aforesaid method.Design of primers can need to consider that the nucleotide sequence held at target protein N end or C adds the nucleotide sequence of code tag albumen (Tagged-protein expression system) according to improving purity, common label protein includes but not limited to His-tag albumen, Flag-tag albumen, GST-tag albumen etc.
Can recombinate, synthesize or be prepared according to polynucleotide of the present invention (as DNA polynucleotide) by the available any method of those skilled in the art.They also can be cloned by standard technique.Usual use recombination method, prepares longer polynucleotide as used PCR (polymerase chain reaction) clone technology.This comprises the pair of primers (according to appointment 12 to 40 Nucleotide) that preparation is positioned at the lipid targeted sequence area flank of required clone, primer is made to contact mRNA or cDNA obtained from ginseng, polymerase chain reaction is carried out under the condition that desired zone can be made to increase, be separated the fragment (as by purification reaction mixture on sepharose) of amplification, and reclaim the DNA of amplification.Can design to introduce makes it comprise applicable Restriction Enzyme recognition site, so that can by the DNA clone of amplification in the cloning vector be applicable to.
As mentioned above, can recombinate, synthesize or be prepared according to polynucleotide of the present invention (as DNA polynucleotide) by the available any method of those skilled in the art.They also can be cloned by standard technique.Usual use recombination method, prepares longer polynucleotide as used PCR (polymerase chain reaction) clone technology.This comprises the pair of primers (according to appointment 15 to 30 Nucleotide) that preparation is positioned at the lipid targeted sequence area flank of required clone, primer is made to contact mRNA or cDNA obtained from ginseng, polymerase chain reaction is carried out under the condition that desired zone can be made to increase, be separated the fragment (as by purification reaction mixture on sepharose) of amplification, and reclaim the DNA of amplification.Can design to introduce makes it comprise applicable Restriction Enzyme recognition site, so that can by the DNA clone of amplification in the cloning vector be applicable to.The design of restriction enzyme site can set according to the nucleotide sequence of vector cloning sites and the encode enzyme or albumen with special properties defined herein; often add several protection bases above, the protection base that can provide with reference to PROMEGA company in detail setting reference manual.
In a specific embodiment of the present invention, described ginseng superoxide-dismutase obtains by expressing arbitrary nucleotide sequence shown below:
A) nucleotide sequence shown in SEQ ID NO.1 of the aminoacid sequence of coding SEQ ID NO:2; And/or
B) nucleotide sequence shown in SEQ ID NO.3 of the aminoacid sequence of coding SEQ ID NO:4; Or
C) nucleotide sequence shown in SEQ ID NO.5 of the aminoacid sequence of coding SEQ ID NO:6.
Term " construct ", namely refers to the carrier built, and it comprises the nucleotide sequence of carrier vector itself and has the enzyme of special properties defined herein or the nucleotide sequence of albumen according to the coding that the present invention uses, and it is connected with promotor directly or indirectly.In some embodiments, preferred construct at least comprises nucleotide sequence of the present invention, or coding has the enzyme of special properties as defined herein or albumen and the nucleotide sequence be operationally connected with promotor.
Term " expression vector " refers to can in vivo or the construct of vivoexpression.It comprises the nucleotide sequence of carrier itself and has the enzyme of special properties defined herein or the nucleotide sequence of albumen according to the coding that the present invention uses, and it is connected with strong promoter directly or indirectly.Preferably, expression vector of the present invention comprises the nucleotide sequence of carrier itself and the nucleotide sequence of described signal peptide-ginseng SOD combination, and expression vector be directed in the genome of biology (as escherichia coli host is biological).Stable being incorporated in genome preferably contained in term " introducing ".
In a specific embodiment of the present invention, provide a kind of expression vector, wherein said expression vector contains arbitrary following nucleotide sequence:
A) nucleotide sequence shown in SEQ ID NO.1; And/or
B) nucleotide sequence shown in SEQ ID NO.3; Or
C) nucleotide sequence shown in SEQ ID NO.5.
Preferably, described expression vector is pET22b.
Nucleotide sequence and the signal peptide sequence of coding ginseng SOD as herein defined may reside in carrier, described in this carrier, nucleotide sequence is operably connected to regulating and controlling sequence, make described regulating and controlling sequence can by be applicable to host cell (as intestinal bacteria) express as described in nucleotide sequence, namely described carrier is expression vector.Carrier of the present invention can be transformed in above-mentioned applicable host cell, to express the enzyme or albumen with coding ginseng SOD activity as herein defined.Usually according to it, host cell be introduced into is selected carrier (as plasmid, clay, virus or phage vector, genomic inserts).The present invention can contain performance identical functions and the expression vector of other known in the art or known form.Once be transformed in selected host cell, carrier can not rely on the genome of host cell and copies and play function, or can be integrated into genome voluntarily.
Described carrier can comprise one or more selected marker, as provided the gene of antibiotics resistance, as provided the gene of amicillin resistance, kalamycin resistance, chlorampenicol resistant or tetracyclin resistance.Carrier can use in vitro, such as, for the preparation of RNA or for transfection or transformed host cell.
Expression vector can comprise the nucleotide sequence that this carrier can be made to copy in described host cell further.Described carrier can be pET 1-46 serial carrier (NOVAGEN company), pGEX serial carrier, pUC serial carrier, pACYC serial carrier, pUB serial carrier, pE serial carrier, pAMB serial carrier and pIJ serial carrier.Be preferably pET serial carrier, most preferably be pET22b.
The detection of above-mentioned nucleotide sequence has been come by nucleotide sequence sequenator, and whether analyze obtained gene by various molecular biology software is goal gene simultaneously.Conventional analysis software has GENTYX, Vector NTI, GenDOC, DNAman, also can carry out off-line and/or on-line search and retrieval analysis in order to comparison nucleotide sequence and protein sequence by means of BLAST and FASTA.
Term as used herein " enzyme " and term " aminoacid sequence " and/or term " polypeptide " and/or term " albumen " synonym.In some instances, term " aminoacid sequence " and term " peptide " and/or " enzyme " synonym, can alternative each otherly use.
Term as used herein " restructuring ginseng SOD " and term " the restructuring ginseng SOD of warm expression " synonym.
Term " signal peptide " is according to sequence used and/or carrier herein, and the ginseng SOD produced by the nucleotide sequence of encoding ginseng SOD by host cell expression can be secreted or be included in cell.Signal sequence may be used for instructing encoding sequence to secrete by specific cytolemma.Described signal sequence can be natural or external source concerning ginseng SOD encoding sequence.Any signal coding sequence that expressed ginseng SOD can be instructed to enter selected host cell (being preferably e. coli bl21 host cell) Secretory Pathway can be used.
The ginseng SOD that can encode natural for the nucleotide sequence of the coding ginseng SOD in either method of the present invention and/or application or ginseng SOD variant.Such as, for the nucleotide sequence of coding ginseng SOD of the present invention can be described in one.These documents of NCBI are incorporated to herein by reference.
Term used herein " ginseng SOD " preferably refers to that having catalysis superoxide radical is converted into hydrogen peroxide and the enzyme of the function that produces oxygen.
Preferably, the superoxide radical in various organism can be converted into hydrogen peroxide for the ginseng SOD in either method of the present invention and/or application and produce oxygen function.Described organism includes but not limited to animal, plant and microorganism.First-selection is animal, is preferably the mankind.
In certain embodiments of the present invention, the nucleotide sequence of coded signal peptide can be operably connected to the nucleotide sequence of the selected ginseng SOD of coding.Selected ginseng SOD can as expressing fusion protein in host cell defined herein.
The aminoacid sequence coded by the nucleotide sequence for the coding ginseng superoxide-dismutase in either method of the present invention and/or application is also contained in the present invention.
The invention provides a kind of transport piece encoding sequence of the ginseng superoxide-dismutase being particularly suitable for expressing in Bacillus coli cells.This sequence filters out according to principles such as e. coli codon preferences.The special encoding sequence ordinary method for rgSOD secreting, expressing designed carries out full genome synthesis, or realized by PCR method.
Term " cell " herein comprises any cell of product that nucleotide sequence of the present invention or coding have the enzyme of special properties as defined herein or the nucleotide sequence of albumen and/or obtained by it, itself and term " biology " and/or term " bacterium " and/or term " microorganism " and/or term " bacterial micro-organism " synonym, replace use each other.As being also contained in this paper term " cell " at the natural ginseng vegetable cell of the native nucleotide sequence containing coding natural ginseng SOD enzyme described by background technology.
The term " engineering cell " relevant with the present invention or " host cell of conversion " comprise and anyly comprise the encode enzyme of special properties that has as defined herein or the nucleotide sequence of albumen and/or the cell of product that obtained by it, and/or wherein promotor can allow the to encode enzyme of the special properties had as defined herein or the nucleotides sequence of albumen is listed in described biology and expresses.Preferred nucleotide sequence is introduced in biological genome.Term " genetically modified organism " is not encompassed in and is in self natural surroundings and is subject to the natural nucleus glycoside coding sequences that it is in the natural promoter control in self natural surroundings together simultaneously.Therefore, genetically modified organism of the present invention comprises the biology comprising following any one or combination: coding has enzyme or the nucleotide sequence of albumen, construct defined herein, carrier defined herein, plasmid defined herein, fixed cell or its product of special properties as defined herein herein.Such as, described genetically modified organism can also comprise coding to be had the enzyme of special properties as defined herein or albumen and is subject to the nucleotide sequence that promotor controls, and wherein said promotor is not connected with restructuring ginseng superoxide-dismutase encoding gene originally.
In yet further embodiment of the invention, provide a kind of engineering cell, wherein said engineering cell is the bacterial cell by obtaining after transforming above-mentioned expression vector and entering host cell.
Described host microorganism can be protokaryon or eukaryote.The nucleotide sequence of ginseng SOD of the present invention or coding ginseng SOD can available from, include but not limited to the bacterial micro-organism with subordinate: Escherichia (Escherichia), Mycobacterium (Mycobacterium), streptococcus (Streptococcus), lactobacillus (Lactobacillus), Desulfitobacterium (Desulfitobacterium), bacillus (Bacillus), campylobacter (Campylobacter), Vibrio (Vibrionaceae), XyZella (Xylella), sulfolobus solfataricus belongs to (Sulfolobus), Aeromonas (Aeromonas), streptomyces (Streptomyces), Saccharomycodes (Saccharomyces), lactococcus (Lactococcus), , Aspergillus (Aspergillus), Schizosaccharomyces (Schizosaccharomyces), listeria (Listeria), Neisseria (Neisseria), Autoinducer belongs to (Mesorhizobium), Lei Er Bordetella (Ralstonia), xanthomonas (Xanthomonas) and mycocandida (Candida), be preferably Escherichia (Escherichia). be preferably Escherichia (Escherichia).
Aptly, the nucleotide sequence of ginseng SOD of the present invention or coding ginseng SOD can available from, preferably available from following bacterial micro-organism: intestinal bacteria (E.coli), genus bacillus (Bacillus sp), campylobacter jejuni (Campylobacter jejuni), vibrios (Vibrionaceae), xyllela fastidiosa (Xylella fastidiosa), solfatara sulfolobus (Sulfolobus solfataricus), yeast saccharomyces cerevisiae (Saccharomyces cerevisiae), Aeromonas hydrophila (Aeromonas hydrophila), aeromonas salmonicida (Aeromonas salmonicida), streptomyces coelicolor (Streptomyces coelicolor), streptomyces rimosus (Streptomyces rimosus), mycobacterium (Mycobacterium), micrococcus scarlatinae (Streptococcus pyogenes), Lactococcus lactis (Lactococcus lactis), Ralstonia solanacearum (Ralstonia solanacearum), xanthomonas campestris (Xanthomonas campestris), Xanthomonas axonopodis (Xanthomonas axonopodis), Candida parapsilosis (Candida parapsilosis), thermophilus streptococcus (Streptococcus thermophilus), lactobacterium helveticus (Lactobacillus helveticus), dehalogenation desulfiting bacterium (Desulfitobacterium dehalogenans), terreus (Aspergillus terreus), schizosaccharomyces pombe (Schizosaccharomyces pombe), listera innocua (Listeria innocua), listerisa monocytogenes in mjme (Listeria monocytogenes), Neisseria meningitidis (Neisseria meningitidis), Root or stem of Littleleaf Indianmulberry Autoinducer (Mesorhizobium loti).Be preferably Bacillus coli cells, be more preferably BL21 (ED3) Bacillus coli cells.
In some embodiments of the invention, prepared some competent cells to be beneficial to external carrier and to be transferred in host cell.Conventional prepare competent cell and comprise subzero treatment.Such as 16 DEG C.
Moreover being suitable for host living beings of the present invention also can be plant.Therefore, the invention still further relates to the method producing and there are the transgenic plant of enhancement of SOD expression level, it comprises the following steps: utilize ginseng superoxide dismutase defined herein (especially utilizing the expression vector or the construct that comprise ginseng superoxide dismutase defined herein) transformed plant cells, and go out plant by the culture plant cell transformed.
In one embodiment, ginseng SOD according to the present invention can be can available from, preferably available from e. coli bl21 JZY001 (Classification And Nomenclature: colon bacillus, Escherichia Coli) ginseng SOD, the microbial preservation budapest treaty that described coli strain JZY001 is used for patented procedure by Jin Zi source, Jilin Province Bioisystech Co., Ltd according to international recognition is deposited in China General Microbiological Culture Collection Center (address: No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City Institute of Microorganism, Academia Sinica, China Committee for Culture Collection of Microorganisms's common micro-organisms center, postcode: 100101) preservation day is on 09 29th, 2014, preserving number is CGMCC9743.
In certain embodiments of the present invention, carried out experimental research to being applicable to the bacterial classification of bacterial micro-organism of the present invention, culture condition, inductive condition and expression fermentation condition etc., described condition also comprises the outside various conditions such as dissolved oxygen, rotating speed and temperature.
After acquisition engineering cell, just can culturing engineering cell under the suitable conditions.Allly be suitable for Escherichia coli Growth, the substratum of expression all can be used for the present invention.Such as, suitable substratum includes, but are not limited to following substratum: LB, potato sugar nutrient agar, bean sprouts medium, pea nutrient agar, potato-sucrose-nutrient agar, potato-sucrose-nutrient agar etc., is preferably LB substratum.
Dissolved oxygen condition can control, and the dissolved oxygen be applicable to controls at 20-90%.The maintenance of dissolved oxygen can solve with oxygen, passing into of air gas mixture.
In another preference, the present invention also by fermentation technology optimization, optimizes the expression condition of rgSOD further.Because expression level is high, reach more than 100mg/L, and be solubility expression, great convenience is brought to purifying process, by two-step chromatography technique, increase substantially product yield, obtain the rgSOD product that expression amount is high, specific activity is high, purification is convenient, yield is high and proterties is stable, greatly reduce production cost, be very applicable to scale operation.
Hold at the 5 ' end and 3 ' of optimized gene and introduce specific cleavage site respectively, by the ordinary method of molecular cloning, optimized gene is cloned into expression vector (as pET28, pET22 etc.).Then, be transformed into BL21 (DE3) host cell, with IPTG induction, shaking flask is expressed and is selected high expression level engineering cell.
After acquisition engineering cell, just can culturing engineering cell under the suitable conditions.Allly be suitable for Escherichia coli Growth, the substratum of expression all can be used for the present invention.Such as, suitable substratum comprises (but being not limited to) following substratum:
A kind of preferred shake flask culture conditions is: the mono-clonal on picking LB flat board, is shake flask culture with LB, is cultured to OD600, use IPTG abduction delivering, and induction 18-21 hour, rgSOD output can reach 50-200mg/L.
In order to scale operation rgSOD, need culturing engineering cell on fermentor tank, express rgSOD, be therefore optimized the pilot scale expression condition of e. coli bl21 (DE3) engineering cell, fermentation-scale is from 1L to 300L, and fermentation capacity is linearly amplified.After optimizing, expression amount is greater than 400mg/L fermented product.
Repeatedly test through of the present invention, expression condition is optimized as follows:
1. for the selection of substratum, during ferment tank, can minimal medium be selected, also necessarily can change on minimal medium basis, but contained ion composition should be similar to minimal medium.
2., with regard to the control of temperature, fermentation and the inducing temperature of rgSOD remain on 16-25 DEG C.
3., with regard to the pH value of inductive phase, inductive phase, pH controlled at 6-8;
4., with regard to the control of dissolved oxygen (DO), DO controls at 20-90%.The maintenance of dissolved oxygen can solve with passing into of oxygen/air mixed gas.
5. with regard to the stream of feed supplement adds, feed supplement kind should comprise the carbon source such as starch, glucose, can feed supplement or mixing feed supplement separately.
6., with regard to inductive phase IPTG concentration, conventional induced concentration all can be used for the present invention, and usual IPTG concentration controls at 0.1-1mM/L.
7. with regard to the usage quantity of Ampicillin Trihydrate, require 100mg-400mg, effectively can suppress varied bacteria growing.
8. with regard to induction time, being not particularly limited, being generally 18-21 hour, is preferably 20 hours.
In certain embodiments of the present invention, extracting ginseng SOD albumen from the bacterium of fermentation.This extractive process is exactly described slightly carrying, and specifically comprises collection thalline, centrifugal acquisition biomass, broken wall stripping albumen, saltouts, the step such as filtration.
The rgSOD expressed is present between cell walls and plasmalemma, and expression level is greater than 200mg/L fermented product, and purifying complex degree is declined greatly.Usually, fermented sample, first with mode collecting cells such as centrifugal or filtrations, is then used N,O-Diacetylmuramidase (4-10mg/g thalline) dissolved cell wall polysaccharide, is made target protein enter in supernatant fluid, and supernatant liquor is containing target protein matter rgSOD.Supernatant liquor by saltouing, the method such as ultrafiltration carries out chromatography purification after carrying out preliminary purification again, also directly chromatography purification can be carried out, describedly saltout as with the thick leach protein of 0-60% neutral sulphates ammonium classification, ultrafiltration ultra-filtration membrane filters, such as, filter with the ultra-filtration membrane that molecular weight cut-off is 10KD.
In certain embodiments of the present invention, the albumen after slightly carrying is further purified.Chromatographic technique comprises the technology such as cation-exchange chromatography, anion-exchange chromatography, gel permeation chromatography, hydrophobic chromatography, affinity chromatography.Compare through different chromatographic technique, chromatography process, the chromatography method of optimization comprises: 1. anion-exchange chromatography: anion-exchange chromatography medium includes but not limited to Q-Sepharose, DEAE-Sepharose.If the salt concn of fermented sample is higher, impact and the combination of Ion Exchange Medium, then need to reduce salt concn before carrying out ion exchange chromatography.Sample can carry out the replacing of level pad by means such as dilution, ultrafiltration, dialysis, gel permeation chromatographies, until with corresponding ion exchange column balance liquid system similarity, then loading, carry out the gradient elution of salt concn or pH; 2. hydrophobic chromatography: hydrophobic chromatoghaphy medium includes but not limited to Phenyl-Sepharose, Butyl-Sepharose, Octyle-Sepharose.Sample is by adding NaCl, (NH4)
2sO
4salt concn is improved, then loading, by reducing salt concn method wash-out etc. mode.The foreign protein of larger difference is had by hydrophobic chromatography removing hydrophobicity.3. gel permeation chromatography hydrophobic chromatoghaphy medium includes, but is not limited to Sephacryl, Superdex, Sephadex class.By gel permeation chromatography exchange buffering system, or consummate further.
Can obtain rgSOD sterling through above-mentioned purifying, purification yield is generally more than 40%, purity more than 95%, and sterling yield is about 200mg/L culture.
RgSOD using conventional procedures after purifying makes various formulation, as lyophilized injectable powder.Select certain stablizer, also can add the protective material such as tensio-active agent, antioxidant simultaneously, and suitably damping fluid carries out lyophilize.The goods obtained have that loss of activity is little, moisture content is low, good stability, be easy to the features such as long-term preservation.RgSOD also can make aqueous injection, sprays, microsphere sustained-release agent, and makes prolonged action preparation etc. through PEG modification.
In an example of the present invention, the BL21 (ED3) constructing rgSOD expresses engineering cell, and IPTG induces, and high-level secretory expression rgSOD, does not need renaturation.
In another example of the present invention, parameter optimization by fermentation, improves the expression level of rgSOD.
Because expressing protein belongs to exocytosis type, do not need brokenly bacterium process.In another example of the present invention, through purifying, obtain rgSOD sterling, purification yield more than 50%, purity more than 95%, sterling yield is about 200mg/L culture.
In another embodiment of the present invention, after purifying, stoste adds suitable auxiliary material, makes the powder ampoule agent for injection of rgSOD.Stability test shows, this powder injection is stablized.
Preferably, the combination of described incubation temperature and incubation time effectively can ensure that the SOD of at least 5% is active, preferably the SOD of at least 10% is active, preferably at least 15%, 20%, 25%, 26%, 28%, 30%, 40%, 50%, 60% or 75% enzyme or protein-active.
In yet another embodiment, sample obtains after the displacement of 10KD film bag ultrafiltration and concentration damping fluid, Q Sepharose F.F. and phenyl sepharose F.F. chromatography that purity is greater than 95%, the sterling of yield more than 50%.
In sum, in a complete embodiment, the invention provides a kind of method preparing restructuring ginseng superoxide-dismutase, wherein, described method comprises the steps:
A) following arbitrary nucleotide sequence is cloned into the step of expression vector pET22b, described nucleotides sequence is classified as: the nucleotide sequence shown in SEQ ID NO.1, and/or the nucleotide sequence shown in SEQ ID NO.3, or the nucleotide sequence shown in SEQ ID NO.5;
B) described expression vector pET22b is transferred to the step of host cell E. coli BL21 (ED3) cell;
C) host cell E. coli BL21 (ED3) cell is carried out culturing step, culture condition comprises: cultivate and be divided into cultivation stage and induction period, cultivation stage is cultivated bacterial concentration and is reached OD600, induction time is 18-21hr, fermentation and inducing temperature remain on 16-25 DEG C, and inductive phase, IPTG concentration was at 0.1-0.2mM/L;
D) separation and purification goes out to melt the step of the restructuring ginseng superoxide-dismutase of nuclear expression, collects thalline, with N,O-Diacetylmuramidase 1mg/g thalline, under 37 DEG C of conditions, process 2 hours to fermented sample by centrifugal and/or filter type, then by centrifugal acquisition clear liquid;
E) by saltout and/or any preliminary purification step is carried out in ultrafiltration, described in saltout as with the thick leach protein of 0-60% neutral sulphates ammonium classification, ultrafiltration ultra-filtration membrane filters, the ultra-filtration membrane of described ultra-filtration membrane to be molecular weight cut-off be 10KD;
F) by anionresin, hydrophobic chromatography method, thus the step that purity reaches the restructuring ginseng superoxide-dismutase of 95-99.9% is obtained.
In yet another embodiment of the present invention, provide and use the purposes of the ginseng SOD for preparing of aforesaid method in the medicine of preparation treatment and human superoxide dismutase relative disease or pathological symptom, food, healthcare products and makeup thereof.Described restructuring ginseng superoxide-dismutase contains arbitrary following aminoacid sequence:
A) aminoacid sequence shown in SEQ ID NO.2; And/or
B) aminoacid sequence shown in SEQ ID NO.4; Or
C) aminoacid sequence shown in SEQ ID NO.6.
Above-mentioned relative disease or pathological symptom include but not limited to: cataract, degenerative ocular fundus pathology, newborn infant's retinopathy, atopic dermatitis, pigmentation blackspot, senile plaque, allergic, hypertension, arteriosclerosis, myocardial infarction, amyocardia, Arrhythmias, nose is irritated, asthma, pulmonary emphysema, pulmonary fibrosis, adult respiratory distress, senile dementia, Parkinson's disease, disturbance of cerebral circulation, sickle anaemia, broad bean disease, lead poisoning, nephropathy, proteinuria, urocystitis, behign prostate hypertrophy, the inflammation of kidney pompon, constipation, halitosis, diabetes and common complication, rheumatic arthritis, cancer, chemotherapy side effect is performed the operation, organ transplantation, hepatitis, climacterium, ageing diseases (aging, aging) etc.
Below in conjunction with specific embodiment, set forth the present invention further.Should be understood that these embodiments are only not used in for illustration of the present invention to limit the scope of the invention.The experimental technique of unreceipted actual conditions in the following example, usually conveniently condition, such as Sambrook etc., Molecular Cloning: A Laboratory guide (New York:ColdSpring Harbor Laboratory Press, 1989); Jan-Christer Janson etc., the condition described in Protein Purification (John Wiley & Sonss, Inc., 1998), or according to the condition that manufacturer advises.
Embodiment
The structure of embodiment 1.rgSOD coli expression carrier:
The design of membranin signal peptide shown in transport piece gene reference e. coli k12 strain secretory protein and SEQ ID NO:2 (Fig. 2), and full genome synthesis, the DNA fragmentation (Fig. 1) of its sequence as shown in SEQ ID NO:1.Aminoacid sequence wherein for the nucleotide sequence of code book invention signal peptide and the signal peptide of the present invention of its deduction is shown in Fig. 7.Introduce NdeI restriction enzyme site at its 5 ' end simultaneously.As shown in SEQ ID NO:4, shown in the aminoacid sequence (Fig. 4) of natural ginseng superoxide-dismutase and SEQ ID NO:3, nucleotide sequence is known (Fig. 3), the Genbank number of logging in as NCBI is respectively AF034630.1 and AAB87572, the acquisition of goal gene is the aminoacid sequence according to natural ginseng superoxide-dismutase, use conventional gene synthesis method, transport piece gene is introduced at 5 ' end of the aminoacid sequence of ginseng superoxide-dismutase, and introduce XhoI restriction enzyme site at 3 ' end of the aminoacid sequence of ginseng superoxide-dismutase, this genes of SEQ ID NO:5 (Fig. 5) encodes secretion peptide-ginseng superoxide-dismutase aminoacid sequence as shown in SEQ ID NO:6 (Fig. 6).The aminoacid sequence corresponding relation inventing the restructuring ginseng SOD of the nucleotide sequence of the restructuring ginseng SOD of warm expression and the warm expression of the present invention of deduction thereof for code book is shown in Fig. 8.
The structure of expression plasmid pET-rgSOD and the acquisition building process of high expression level engineering cell are as shown in Figure 9.Secretion peptide-superoxide-dismutase full genome NdeI+XhoI restriction endonuclease (the deriving from NEB Biolab) enzyme of synthesis is cut, carrier pET22b is carried out enzyme with identical NdeI+XhoI to cut simultaneously, then NEB TAKARADNA ligase enzyme (solution 1 is used, TAKARA, DaLian, China) connect in pET22b carrier, obtain pET-rgSOD, order-checking confirms that DNA sequence dna is correct.Then, by pET-rgSOD plasmid, be converted in e. coli bl21 (DE3), under 37 DEG C of conditions, determine after inducing 4 hours with IPTG to express ginseng superoxide-dismutase (Figure 10).
Embodiment 2 temperature is on the impact of rgSOD expression level
Get mono-clonal, be inoculated in LB primary seed solution, cultivate 17-20hr; Get 3 50mL culture tubes, ratio in 1: 50 is inoculated in the 50mL culture tube of three 5mL substratum respectively, cultivate about 4hr, 1mM/LIPTG induction, inducing temperature is respectively 16 DEG C, 25 DEG C, 37 DEG C, collect thalline, with N,O-Diacetylmuramidase under 37 DEG C of conditions, process 2 hours, centrifugal 10 minutes of 15000rpm, get supernatant, SDS-PAGE detects expression.Experimental result shows, expresses rgSOD at 16 DEG C, 25 DEG C all almost almost in shaking flask, but 37 DEG C of expression-secretion albumen relatively less (Figure 11).
Embodiment 3IPTG concentration is on the impact of rgSOD expression level
Get mono-clonal, be inoculated in LB primary seed solution, cultivate 17-20hr; Ratio in 1: 50 is inoculated in 5 respectively and is equipped with in the 50mL culture tube of 5mL substratum, cultivate about 4hr for 37 DEG C, be cooled to 20 DEG C, add IPTG respectively, make concentration in substratum be 0.6mM, 0.4mM, 0.2mM, 0.1mM induction, collect thalline, with N,O-Diacetylmuramidase under 37 DEG C of conditions, process 2 hours, centrifugal 10 minutes of 15000rpm, get supernatant, SDS-PAGE detects expression.Experimental result shows, several gradient concentration IPTG induces rgSOD expression amount similar, with the IPTG concentration induction ratio less expensive of 0.1mM, cost-saving (Figure 12).
Embodiment 4. pilot scale fermentation condition is selected and is optimized NBS BioFlo 3000 fermentor tank (6.5L) after above-mentioned optimization, and rgSOD expression amount is about 300mg/L fermented liquid, and expression amount obviously increases (Figure 13).
Centrifugal 10 minutes of 5000rpm at the fermented product 4 DEG C of embodiment 5.rgSOD purifying embodiment 4, collect thalline, dissolve thalline with N,O-Diacetylmuramidase, lytic enzyme usage quantity is 1mg/g thalline, and 37 DEG C of temperature are bathed 2 hours.From 15000rpm centrifugal segregation thalline, collect clear liquor.Use Millipore ultra-fine filter, the ultra-filtration membrane molecular weight that dams is 10KD, leaves and takes phegma during ultrafiltration.Supernatant ultrafiltration is left about 500ml to volume, adds with 10mM phosphate buffered saline buffer (PB, pH7.4), continues ultrafiltration; This program repeatedly, until the conductance of the conductivity water of sample gentle 10mM PB (pH7.4) damping fluid is on close level.
Anion-exchange chromatography: chromatography media: Q Sepharose F.F. (Phamarcia) damping fluid: solution A: 10mM PBS (pH7.4), solution B: 10mM PB+1M NaCl (pH7.4) loading: by rgSOD solution (about the 1L of ultrafiltration and concentration, conductance is about 4000us/cm) loading cleaning: by the solution A cleaning chromatography column gradient of 6CV (column volume, lower same) after loading: directly collect with 30% solution B wash-out target protein after cleaning: the protein chromatographic under collection 30%B wash-out.
Hydrophobic chromatography: phenyl-sepharose (Phamarcia) damping fluid: solution A: 10mM PBS (pH 7.4), solution C: 10mM PB+3M NaCl (pH7.4) loading: the sample that chromatography 1 obtains is added solid NaCl to 3.0M, loading gradient: 100%A directly cleans collection: the target protein sample under collection 100%A washes is through this 2 step chromatography, namely after anion-exchange chromatography, hydrophobic chromatography, purity is increased to 95% (Figure 14), the yield rgSOD sterling more than 50%, sterling yield 200mg/L culture.
The vigour-testing method of SOD
The assay NBT photoreduction of improvement is simple, comparatively practical.Chemoluminescence method and Nitrite formation method are not suitable for mensuration Mn-SOD, but extremely sensitive for Cu/Zn-SOD reaction.Cyte reduction method is used for Mn-SOD vitality test result and stablizes, reproducible.But specificity and insufficient sensitivity ideal, and need specific apparatus, practical application is restricted.Nitrite forming method combines with CN-inhibitor or SDS process, be applied to Mn-SOD to measure, remolding sensitivity Cyte reduction method improves several times, and specificity is strong, reproducible, easy to operate, do not need specific apparatus and equipment, being easy to practical application and popularization, is current one of measuring method preferably.Under normal circumstances, SOD enzyme activity measures and can only apply indirect activity assay method.According to SOD national standard, our company adopts improvement Marklund method, i.e. mouse thymus cells method.
1 definition: suppress pyrogallol required SOD amount when oxygen words speed 50% to be a unit of activity when 25 DEG C.
2 principles: in the basic conditions, can there is autoxidation in pyrogallol, mouse thymus cells ability can be suppressed to measure SOD vigor according to SOD.
3 reagent: A liquid: pH8.200.1mol/L tri-rifle aminomethane (Tris)-hydrochloride buffer (including 1mmol/L EDTA.2Na).Take 1.214g Tris and 37.2mg EDTA.2Na to be dissolved in 62.4mL 0.1mol/L hydrochloric acid soln, be settled to 100ml with distilled water.B liquid: 4.5mmol/L pyrogallol hydrochloric acid soln.Take pyrogallol (A.R) 56.7mg to be dissolved in a small amount of 10mmol/L hydrochloric acid and to be dissolved in, and be settled to 100mL.
4 instruments: ultraviolet-visible spectrophotometer, secret acidometer, tolerance range 0.01pH, whizzer, 10mL cuvette, 10mL centrifuge tube, glass mortar.
The preparation of 5 samples:
6 analytical procedures: mouse thymus cells rate determination, at about 25 DEG C, once add A liquid 2.35mL in 10mL cuvette, distilled water 2mL, B liquid 0.15mL.Add B liquid to mix immediately and impouring cuvette, light absorption value after initial and 1min under being determined at 325 wavelength condition respectively, the difference of the two and mouse thymus cells speed △ A
325(min
-1). △ A is determined in this test
325(min
-1) be 0.060.SOD determination of activity application of sample programsheet is as follows:
| Test solution | Blank | Sample liquid | SOD liquid |
| A liquid/ml | 2.35 | 2.35 | 2.35 |
| Distilled water/ml | 2 | 1.8 | 1.8 |
| Sample liquid or SOD liquid/ul | 0 | 20 | 20 |
| B liquid/ml | 0.15 | 0.15 | 0.15 |
7 results calculate: liquid sample is calculated as follows:
In formula:
U/mL:SOD enzyme activity unit
△ A325: mouse thymus cells speed
△ A ' 325: sample liquid or SOD enzyme liquid suppress mouse thymus cells speed
V: the enzyme-added liquid of institute or sample liquid volume, unit is milliliter (mL)
D: the extension rate of enzyme liquid or sample liquid
4.5: reaction solution cumulative volume, unit is milliliter (mL)
Calculation result retains 3 position effective digitals.
Solid sample calculation formula is as follows:
In formula:
U/g:SOD enzyme activity unit
△ A325: mouse thymus cells speed
△ A ' 325: sample liquid or SOD enzyme liquid suppress mouse thymus cells speed
V: the enzyme-added liquid of institute or sample liquid volume, unit is milliliter (mL)
V1: sample liquid cumulative volume, unit is milliliter (mL)
D: the extension rate of enzyme liquid or sample liquid
M: sample quality, unit is gram (g)
4.5: reaction solution cumulative volume, unit is milliliter (mL)
Calculation result retains three position effective digitals.
The all documents mentioned are quoted as a reference all in this application, are just quoted separately as a reference as each section of document.In addition should be understood that those skilled in the art can make various changes or modifications the present invention after having read above-mentioned teachings of the present invention, these equivalent form of values fall within the application's appended claims limited range equally.
The present invention does not limit to the particular implementation described in this application, as the unitary declaration of independent aspect of the present invention.Various amendment and change is carried out when it will be understood by those skilled in the art that the spirit and scope that can not depart from the application.According to above description, except enumerating herein, the functionally equivalent purposes in the scope of the present disclosure is obvious for those skilled in the art of this area.Such change and amendment are intended to fall within the scope of the appended claims.The disclosure only by claims and with such claim the four corner that is equal to of scope limit.Should be appreciated that the disclosure is not limited to specific method, reagent, composition and biosystem, certainly, described method, reagent, composition and biosystem can change.It can also be appreciated that term used herein only for describing specific embodiment, it is restrictive for not being used for.
All patents that are referred herein or that quote, patent application, earlier application and publication are incorporated to herein by reference and in full, comprise all accompanying drawings and form, they are not contradicted with the clearly instruction of this specification sheets.Other embodiment is proposed in right.
Claims (10)
1. a restructuring ginseng superoxide-dismutase, it is characterized in that, described ginseng superoxide-dismutase comprises arbitrary following aminoacid sequence:
A) aminoacid sequence shown in SEQ ID NO.2; And/or
B) aminoacid sequence shown in SEQ ID NO.4; Or
C) aminoacid sequence shown in SEQ ID NO.6.
2. the nucleic acid molecule be separated, it is characterized in that, the nucleic acid molecule of described separation comprises arbitrary following nucleotide sequence:
A) nucleotide sequence shown in SEQ ID NO.1 of the aminoacid sequence of coding SEQ ID NO:2; And/or
B) nucleotide sequence shown in SEQ ID NO.3 of the aminoacid sequence of coding SEQ ID NO:4; Or
C) nucleotide sequence shown in SEQ ID NO.5 of the aminoacid sequence of coding SEQ ID NO:6.
3. a restructuring ginseng superoxide-dismutase, is characterized in that, described ginseng superoxide-dismutase obtains by expressing arbitrary nucleotide sequence shown below:
A) nucleotide sequence shown in SEQ ID NO.1 of the aminoacid sequence of coding SEQ ID NO:2; And/or
B) nucleotide sequence shown in SEQ ID NO.3 of the aminoacid sequence of coding SEQ ID NO:4; Or
C) nucleotide sequence shown in SEQ ID NO.5 of the aminoacid sequence of coding SEQ ID NO:6.
4. an expression vector, is characterized in that, described expression vector contains arbitrary following nucleotide sequence:
A) nucleotide sequence shown in SEQ ID NO.1; And/or
B) nucleotide sequence shown in SEQ ID NO.3; Or
C) nucleotide sequence shown in SEQ ID NO.5.
5. expression vector as claimed in claim 4, it is characterized in that, described expression vector is pET22b.
6. an engineering cell, is characterized in that, described engineering cell is the bacterial cell by obtaining after transforming expression vector according to claim 4 and entering host cell.
7. engineering cell as claimed in claim 5, it is characterized in that, described engineering cell is e. coli bl21 (ED3) cell.
8. prepare a method for restructuring ginseng superoxide-dismutase, it is characterized in that, described method comprises:
A) arbitrary nucleotide sequence according to claim 3 is cloned into the step of expression vector pET22b;
B) described expression vector pET22b is transferred to the step of host cell E. coli BL21 (ED3) cell;
C) host cell E. coli BL21 (ED3) cell is carried out culturing step, culture condition comprises: cultivate and be divided into cultivation stage and induction period, cultivation stage is cultivated bacterial concentration and is reached OD600, induction time is 18-21hr, fermentation and inducing temperature remain on 16-25 DEG C, and inductive phase, IPTG concentration was at 0.1-0.2mM/L;
D) separation and purification goes out to melt the step of the restructuring ginseng superoxide-dismutase of nuclear expression, collects thalline, with N,O-Diacetylmuramidase 1mg/g thalline, under 37 DEG C of conditions, process 2 hours to fermented sample by centrifugal and/or filter type, then by centrifugal acquisition clear liquid;
E) by saltout and/or any preliminary purification step is carried out in ultrafiltration, described in saltout as with the thick leach protein of 0-60% neutral sulphates ammonium classification, ultrafiltration ultra-filtration membrane filters, the ultra-filtration membrane of described ultra-filtration membrane to be molecular weight cut-off be 10KD;
F) by anionresin, hydrophobic chromatography method, thus the step that purity reaches the restructuring ginseng superoxide-dismutase of 95-99.9% is obtained.
9. restructuring ginseng superoxide-dismutase is preparing the purposes in the medicine for the treatment of and human superoxide dismutase relative disease or pathological symptom, food, healthcare products and makeup thereof.
10. method as claimed in claim 8 or purposes according to claim 10, it is characterized in that, described restructuring ginseng superoxide-dismutase contains arbitrary following aminoacid sequence:
A) aminoacid sequence shown in SEQ ID NO.2; And/or
B) aminoacid sequence shown in SEQ ID NO.4; Or
C) aminoacid sequence shown in SEQ ID NO.6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410535835.7A CN104342409B (en) | 2014-06-17 | 2014-10-12 | Recombinate the preparation method of ginseng superoxide dismutase |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410267679.0 | 2014-06-17 | ||
| CN201410267679 | 2014-06-17 | ||
| CN2014102676790 | 2014-06-17 | ||
| CN201410535835.7A CN104342409B (en) | 2014-06-17 | 2014-10-12 | Recombinate the preparation method of ginseng superoxide dismutase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104342409A true CN104342409A (en) | 2015-02-11 |
| CN104342409B CN104342409B (en) | 2018-05-25 |
Family
ID=52498871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410535835.7A Active CN104342409B (en) | 2014-06-17 | 2014-10-12 | Recombinate the preparation method of ginseng superoxide dismutase |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104342409B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112912059A (en) * | 2018-09-03 | 2021-06-04 | 阿特拉生物科技股份公司 | Industrial use of plant cell extracts containing SOD enzymes of extreme microorganisms |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0236385B1 (en) * | 1985-09-03 | 1991-11-13 | Symbicom Ab | A superoxide dismutase |
| CN101525600A (en) * | 2009-03-27 | 2009-09-09 | 陕西省微生物研究所 | Method for improving output of recombinant human Cu, Zn-SOD activated protein |
| CN103333913A (en) * | 2013-07-08 | 2013-10-02 | 中国人民解放军疾病预防控制所 | Engineering saccharomyces cerevisiae being capable of secreting and expressing superoxide dismutase, and construction method thereof and applications of same in preparation of active beauty products |
-
2014
- 2014-10-12 CN CN201410535835.7A patent/CN104342409B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0236385B1 (en) * | 1985-09-03 | 1991-11-13 | Symbicom Ab | A superoxide dismutase |
| CN101525600A (en) * | 2009-03-27 | 2009-09-09 | 陕西省微生物研究所 | Method for improving output of recombinant human Cu, Zn-SOD activated protein |
| CN103333913A (en) * | 2013-07-08 | 2013-10-02 | 中国人民解放军疾病预防控制所 | Engineering saccharomyces cerevisiae being capable of secreting and expressing superoxide dismutase, and construction method thereof and applications of same in preparation of active beauty products |
Non-Patent Citations (8)
| Title |
|---|
| J. H. CHOI，S. Y. LEE: "Secretory and extracellular production of recombinant proteins using Escherichia coli", 《APPL MICROBIOL BIOTECHNOL》 * |
| KIM ET AL.: "GenBank：AAB87572.1", 《NCBI》 * |
| KIM ET AL.: "GenBank：AF034630.1", 《NCBI》 * |
| UNIPROTKB/SWISS-PROT: "P76471", 《SIGNAL PEPTIDE DATABASE-BACTERIA》 * |
| 何冰芳等: "大肠杆菌蛋白质分泌机理及其重组蛋白分泌表达新进展", 《食品与生物技术学报》 * |
| 张琨等: "耐热、高产重组人Cu, Zn-SOD改构体的构建及纯化方法的研究", 《西北大学学报(自然科学版)》 * |
| 李振国等: "在大肠杆菌周质表达重组蛋白的研究进展", 《药物生物技术》 * |
| 林菊生主编: "《现代细胞分子生物学技术》", 31 August 2004, 科学出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112912059A (en) * | 2018-09-03 | 2021-06-04 | 阿特拉生物科技股份公司 | Industrial use of plant cell extracts containing SOD enzymes of extreme microorganisms |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104342409B (en) | 2018-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109055327B (en) | Aldehyde ketone reductase mutant and application thereof | |
| CN104651287A (en) | Engineering bacterium for synthesizing glycosylglycerol and application thereof | |
| CN113528476A (en) | Glucose oxidase mutant and coding gene and efficient recombinant expression thereof | |
| KR102186997B1 (en) | Novel method of protein purification | |
| CN114525214B (en) | Construction method and application of engineering probiotics | |
| CN114507658B (en) | Enzyme coexpression system and application thereof in synthesizing sialic acid | |
| CN107257851A (en) | Positive influences are natural or combination of bacterial chaperonin of physiology of eukaryotic of engineering | |
| CN114277004B (en) | High-temperature-resistant recombinant mutant SOD and encoding gene and application thereof | |
| CN113430181B (en) | Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof | |
| CN108034667A (en) | A kind of red monascus alpha-amylase gene, its preparation method and application | |
| CN104342409A (en) | Preparation method of recombinant ginseng superoxide dismutase (rgSOD) | |
| CN104342408B (en) | Recombinate the preparation method of Cordyceps militaris superoxide dismutase | |
| CN110628790A (en) | Pyranose oxidase gene, protein and pichia pastoris constructed by utilizing molecular chaperones, and preparation and application thereof | |
| JP2021517806A (en) | Use in the production of recombinant microorganisms, their production methods and coenzyme Q10 | |
| US20190330600A1 (en) | Glutathione reductase | |
| CN111117980B (en) | Esterase derived from Antarctic soil, and coding gene and application thereof | |
| CN107254452A (en) | A kind of preparation and application of the anti-oxidant protease of microbial source | |
| CN117460821A (en) | Recombinant cell for producing hyaluronic acid | |
| CN113736806A (en) | Gene for improving oil synthesis of marine nannochloropsis and application thereof | |
| CN108690837B (en) | Method for improving heat stability of polymer protein and alcohol dehydrogenase with improved heat stability | |
| CN108753810B (en) | Application of transcriptional regulatory protein gene ORF2 | |
| CN108018265B (en) | Inositol oxidase mutant and coding gene and application thereof | |
| CN108265068B (en) | Recombinant arginine deiminase and industrial preparation method and application thereof | |
| KR100947376B1 (en) | A method for producing a Recombinant protein using a GAL80 Deficient Yeast Strain | |
| CN113684195B (en) | Sterol esterase and coding gene and mutant thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: The 136400 industrial parks in Siping City of Jilin province Shuangliao City Economic Development Zone (Fuyao road and the Street Interchange) Applicant after: Jilin gold Ziyuan biological Polytron Technologies Inc Address before: The 136400 industrial parks in Siping City of Jilin province Shuangliao City Economic Development Zone (Fuyao road and the Street Interchange) Applicant before: Jilin Jinziyuan Biological Science & Technology Co., Ltd. |
|
| COR | Change of bibliographic data | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |